Advertisement
UK markets close in 7 hours 15 minutes
  • FTSE 100

    8,075.96
    +35.58 (+0.44%)
     
  • FTSE 250

    19,633.99
    -85.38 (-0.43%)
     
  • AIM

    753.93
    -0.76 (-0.10%)
     
  • GBP/EUR

    1.1666
    +0.0021 (+0.18%)
     
  • GBP/USD

    1.2513
    +0.0050 (+0.40%)
     
  • Bitcoin GBP

    51,197.48
    -2,195.47 (-4.11%)
     
  • CMC Crypto 200

    1,331.41
    -51.16 (-3.70%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.12
    +0.31 (+0.37%)
     
  • GOLD FUTURES

    2,341.00
    +2.60 (+0.11%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,269.04
    +67.77 (+0.39%)
     
  • DAX

    18,002.35
    -86.35 (-0.48%)
     
  • CAC 40

    8,068.50
    -23.36 (-0.29%)
     

Have Insiders Been Buying Auris Medical Holding Ltd. (NASDAQ:EARS) Shares?

We often see insiders buying up shares in companies that perform well over the long term. Unfortunately, there are also plenty of examples of share prices declining precipitously after insiders have sold shares. So shareholders might well want to know whether insiders have been buying or selling shares in Auris Medical Holding Ltd. (NASDAQ:EARS).

What Is Insider Buying?

It's quite normal to see company insiders, such as board members, trading in company stock, from time to time. However, rules govern insider transactions, and certain disclosures are required.

We would never suggest that investors should base their decisions solely on what the directors of a company have been doing. But equally, we would consider it foolish to ignore insider transactions altogether. For example, a Columbia University study found that 'insiders are more likely to engage in open market purchases of their own company’s stock when the firm is about to reveal new agreements with customers and suppliers'.

ADVERTISEMENT

View our latest analysis for Auris Medical Holding

The Last 12 Months Of Insider Transactions At Auris Medical Holding

The Founder Thomas Meyer made the biggest insider purchase in the last 12 months. That single transaction was for US$99k worth of shares at a price of US$0.80 each. Even though the purchase was made at a significantly lower price than the recent price (US$3.05), we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

Auris Medical Holding is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

Does Auris Medical Holding Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Based on our data, Auris Medical Holding insiders have about 5.0% of the stock, worth approximately US$1.7m. We consider this fairly low insider ownership.

So What Does This Data Suggest About Auris Medical Holding Insiders?

It's certainly positive to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that Auris Medical Holding insiders are expecting a bright future. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Case in point: We've spotted 4 warning signs for Auris Medical Holding you should be aware of, and 2 of them are a bit unpleasant.

Of course Auris Medical Holding may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.